As a working group of the All of Us Research Program Advisory Panel, the Genomics Working Group provided information on the available options for All of Us to consider as it develops a comprehensive genomics strategy. Deliberations addressed the rapidly evolving nature of genome sequencing and variant annotation technologies and considered the program’s commitment to the return of information to participants.
The Genomics Working Group prepared a report for the All of Us Research Program Advisory Panel to consider as the program develops a comprehensive genomics strategy. The report provides information on the pros and cons of different approaches and options for corresponding implementation plans, and encompasses effective strategies to generate, analyze, and manage genomic data at the scale of All of Us. Recommendation of approaches for the responsible return of genetic results were not within the scope of this group but will be considered in the context of the genomics strategy.
The mission of the All of Us Research Program is to accelerate health research and medical breakthroughs by partnering with 1 million or more participants across the United States to provide the most diverse biomedical data resource in history. Participants will complete surveys about their lifestyle, health, and environment; share data from their electronic health records; undergo physical measurements; and provide biospecimens. They may also contribute other biometric or lifestyle data. All of Us will generate genomic data on 1 million or more participants, although the details about timing and scale remain to be fully established. In addition, All of Us will provide access to results, including genetic/genomic information, to participants according to their preferences.
Lon Cardon, Ph.D., Chief Scientific Officer, BioMarin Pharmaceutical
Debbie Nickerson, Ph.D., Professor of Genome Sciences, University of Washington
Gonçalo Abecasis, D.Phil., Professor, Department of Biostatistics, University of Michigan
Wendy Chung, M.D., Ph.D., Associate Professor of Pediatrics, Columbia University
Joshua Denny, M.D., Associate Professor of Medicine, Vanderbilt University School of Medicine
Caroline Fox, M.D., M.P.H., Vice President and Head, Human Genetics and Pharmacogenomics, Merck Research Laboratories
Eric Green, M.D., Ph.D., Director, National Human Genome Research Institute
Joel Hirschhorn, M.D., Ph.D., Professor of Pediatrics and Professor of Genetics, Boston Children’s Hospital
Howard Jacob, Ph.D., Executive Vice President, HudsonAlpha Institute for Biotechnology
Sekar Kathiresan, M.D., Director, Cardiovascular Disease Initiative, Eli and Edythe L. Broad Institute of MIT and Harvard
Eimear Kenny, Ph.D., Assistant Professor of Genetics and Genome Sciences, Icahn School of Medicine at Mount Sinai
Christopher O’Donnell, M.D., Chief of Cardiology, VA Boston Healthcare System
Brad Ozenberger, Ph.D., Program Director, All of Us Research Program, National Institutes of Health
Heidi Rehm, Ph.D., Director, Laboratory for Molecular Medicine, Partners HealthCare
Jay Shendure, M.D., Ph.D., Associate Professor of Genome Sciences, University of Washington
Alan Shuldiner, M.D., Vice President of Translational Genetics, Regeneron Pharmaceuticals, Inc.
Karl Surkan, Ph.D., Lecturer, Massachusetts Institute of Technology
Sharon Terry, President and Chief Executive Officer, Genetic Alliance